SUCCESSFUL TREATMENT OF INOPERABLE THROMBOEMBOLIC PULMONARY HYPERTENSION PATIENT WITH SILDENAFIL IN HIGH DOSES

The currentguidelines on chronic thromboembolic pulmonary hypertension (CTEPH) treatment consider pulmonary thrombendarterectomy as the first therapy choice. In case of inoperability due to severe patient's condition, distal lesions of pulmonary vessels, extremely high pulmonary vascular resistance, medical treatment for CTEPH includes life-long anticoagulation therapy and reduction of heart failure symptoms. This clinical case of the 59-y-old patient M. with inoperable CTEPH demonstrates the efficacy of phosphodiеsterase-5 inhibitor Sildenafil usedin high doses. The diagnosis was confirmed by the results of the complete diagnostic process including right heart catheterization and pulmonary angiography. The initial functional class was assessed as III in accordance with WHO classification. Sildenafil 60 mg daily was added tothe standard therapy (anticoagulant, calcium channel blocker) for initial four weeks. To the 4wk visit Sildenafil dose was increased to 240 mgdailytaking into account good tolerance of the treatment.The significant improvement of functional class, positive dynamic ofhemodynamic and echo parameters were found to 4 month of follow-up.

легочная гипертензия, хроническая тромбоэмболическая лёгочная гипертензия, ингибитор фосфодиэстеразы типа 5, силденафил, pulmonary hypertension, chronic thromboembolic pulmonary hypertension, phosphodiesterase type 5 inhibitor, sildenafil

1. Ротберг Г.Е., Струтынский А.В., Внутренние болезни. Сердечно-сосудистая система. Глава 14: Тромбоэмболия легочной артерии и острое легочное сердце. 2003г.: 839-853.

2. Riedel M., Stanek V., Widimsky J. et. al. Long-term follow-up of patients with pulmonary thromboembolism: late prognosis and evolution of hemodynamic and respiratory data. Chest 1982; 81: 151-8.

3. Sasahara A.A., Sharma J.V. R.K., Barsamian E.M. et al. Pulmonary thromboembolism, diagnosis and treatment. 1983; 249-2945-2949.

4. Tapson V.F., M. Humbert. Incidence and Prevalence of Chronic Thromboembolic Pulmonary Hypertension. ProcAmThoracSoc 2206; 3: 564-567.

5. Pengo V., Lensing A.W., Prins M.H., et al. incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med. 2004; 350; 2257-64.

6. Рекомендации Европейского общества кардиологов и Европейского респираторного общества по диагностике и лечению легочной гипертензии 2009 г.

7. Reichenberger F., Voswinckel R., Enke B., Rutsch M., El Fechtali E., Schmehl T., Long-termtreatment with sildenafil in chronic thromboembolic pulmonary hypertension

8. Ghofrani H.A., Schermuly R.T., Rose F., Wiedemann R. Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertension. Am J RespirCrit Care Med. 2003b; 167: 1139-41.

9. Chronic Thromboembolic Pulmonary Hypertension Soluble Guanylate Cyclase-Stimulator Trial.